Lupin Recalls Quinapril 5mg Tablets Due to Impurity Issues
Lupin Pharmaceuticals recalls specific bottles of Quinapril Tablets USP 5 mg due to failed impurity specifications. Check your medication details below.
Recall notice
Failed Impurities/Degradation Specifications; Impurity A
Contact the company
What happened, in plain English
Lupin Pharmaceuticals Inc. is recalling Quinapril Tablets USP 5 mg in 90-count bottles because they contain failed impurities or degradation products, specifically Impurity A. The recall affects a specific batch with an expiration date of March 2016. No further details on the health risks or remedy are provided in this record. Read more at govinfonow.com/recall/43346-lupin-recalls-quinapril-5mg-tablets-due-to-impurity-issues.
Source Summary by GovInfoNow · govinfonow.com/recall/43346-lupin-recalls-quinapril-5mg-tablets-due-to-impurity-issues · Updated October 11, 2026 · FDA enforcement record: FDA #D-0650-2017
Cite this page
“Lupin Recalls Quinapril 5mg Tablets Due to Impurity Issues.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43346-lupin-recalls-quinapril-5mg-tablets-due-to-impurity-issues. Based on FDA recall #D-0650-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0650-2017%22&limit=1).
Why it’s dangerous
The recalled tablets failed impurity or degradation specifications due to the presence of Impurity A. The provided record does not describe what Impurity A is, how it forms, or what specific health risks it poses to consumers.
Who’s affected
Consumers who purchased Quinapril Tablets USP 5 mg from Lupin Pharmaceuticals Inc., specifically those with NDC 68180-556-09 and batch number G303703. The record does not specify which health conditions are treated by this medication.
How to tell if you have this one
Check your medication bottle for the following details: Brand: Lupin Pharmaceuticals Inc., Product: Quinapril Tablets USP 5 mg, Count: 90 bottles, NDC: 68180-556-09, Batch number: G303703, Expiration date: 3/2016.
- Brand
Lupin Pharmaceuticals- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 16 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- FDA terminated the recall
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
Where was this medication sold?
The distribution pattern for this recall was nationwide across the United States.
Similar recalls
Other Lupin Pharmaceuticals recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0650-2017 (December 7, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0650-2017 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.